After Heart Failure Hospitalization, VERQUVO® (vericiguat) May Help You Live Longer and Stay Out of the Hospital

Sign up for our patient support program, Verquvo at Heart

Verquvo® At Heart Logo

Looking for support to help you move forward after your heart failure hospitalization? Verquvo at Heart is here to help support patients who have been prescribed VERQUVO for an approved indication.

Talk with your doctor if you have any questions about VERQUVO. Any questions and concerns you have regarding your condition, treatment, or side effects should be directed to your healthcare provider. Verquvo at Heart is meant to be an additional resource.

What you can expect from Verquvo at Heart

Individualized support

1-on-1 telephone support from a dedicated coach who can assist you in getting started on VERQUVO and pursuing your lifestyle and treatment goals.

Helpful tips

Get tips on diet, staying active, healthy living, goal setting, and more.

Engaging tools

  • Patient brochure
  • Caregiver brochure

Support along the way

Receive support via email and text to help you manage your heart failure.

Sign up below or by calling 1-855-272-5121.

Please enter your information. All fields are required.

Click “COMPLETE SIGN-UP” below to access additional resources that may be helpful. You must first authorize our use and sharing of the information you provide to us, as described below. For more information about how Merck protects personal information about you, please read the Internet Privacy Policy and Privacy Notice for patients, consumers, and caregivers.

Your Permission

By clicking the check-box and “COMPLETE SIGN-UP” button below, you agree to permit the Merck & Co. family of companies and others working on their behalf (collectively, “Merck” or “we” or “us”) to use the personal information, including any health information, that you provide here or in subsequent communications with us related to VERQUVO and the VERQUVO Patient Support Program (“Your Information”) to communicate with you about VERQUVO and the VERQUVO Patient Support Program via email or otherwise. Additionally, we may use Your Information to contact you for market research purposes and to analyze Your Information for those purposes, as well as to develop and offer additional services and communications that we believe you or others might find of interest and for compliance and security purposes. At any time, you may withdraw this permission by calling 1-888-776-8364. Prior actions taken in reliance on this authorization prior to any withdrawal will not be affected. Unless you withdraw the permission sooner, it will expire 1 (one) year from the date when you click the check-box and “COMPLETE SIGN-UP” button below. By clicking the check-box and “COMPLETE SIGN-UP” button below, you are signing this written permission for use of Your Information as described above. You may print or download this permission after you have signed it, or call us at 1-888-776-8364 to request that we mail you a hard copy.

I confirm that I am 18 years of age or older and that I agree to the terms and conditions above.

Looking for additional information, tips, and tools?

What is VERQUVO?

VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent to reduce the risk of dying and to reduce the need to be hospitalized.


VERQUVO may cause birth defects if taken during pregnancy.

  • Females must not be pregnant when they start taking VERQUVO.
  • For females who are able to get pregnant:
  • Your healthcare provider will do a pregnancy test to make sure that you are not pregnant before you start taking VERQUVO.
  • You must use effective forms of birth control during treatment and for 1 month after you stop treatment with VERQUVO. Talk to your healthcare provider about forms of birth control that you may use to prevent pregnancy during treatment.
  • Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with VERQUVO.
  • There is a Pregnancy Surveillance Program that monitors pregnancy outcomes in women exposed to VERQUVO during pregnancy. Patients should report any exposure to VERQUVO during pregnancy by calling  1-877-888-4231or at

Do not take VERQUVO if you:

  • are taking another medicine called a soluble guanylate cyclase stimulator (sGC). Ask your healthcare provider if you are not sure if you are taking an sGC medicine.
  • are pregnant.

Before taking VERQUVO, tell your healthcare provider about all your medical conditions, including if you:

  • are breastfeeding or plan to breastfeed. It is not known if VERQUVO passes into your breast milk. Do not breastfeed if you take VERQUVO. Talk with your healthcare provider about the best way to feed your baby if you take VERQUVO.

Tell your healthcare provider about all the medicines you take. Certain other medicines may affect how VERQUVO works.

The most common side effects of VERQUVO include:

  • low blood pressure
  • low red blood cells (anemia)

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit or call 1-800-FDA-1088.

Please read the accompanying Medication Guide for VERQUVO, including the information about birth defects if taken during pregnancy, and discuss it with your doctor. The physician Prescribing Information also is available.